Wickersham Health Campus

CLIA Laboratory Citation Details

3
Total Citations
12
Total Deficiencyies
6
Unique D-Tags
CMS Certification Number 24D0995625
Address 1421 Premier Dr, Mankato, MN, 56001
City Mankato
State MN
Zip Code56001
Phone507 381-0241
Lab DirectorJAMES DUNGAN

Citation History (3 surveys)

Survey - October 27, 2025

Survey Type: Standard

Survey Event ID: 06OO11

Deficiency Tags: D0000 D0000 D5807 D6000 D6015 D5807 D6000 D6015

Summary:

Summary Statement of Deficiencies D0000 . The Wickersham Health Campus laboratory was found to be out of compliance with the regulations of the Clinical Laboratory Improvement Amendments of 1988 (42 C.F. R. part 493) upon completion of the recertification survey performed on October 23, 2025. The following condition-level deficiency was cited: 493.1403 Laboratories performing moderate complexity testing; laboratory director. The following standard- level deficiencies were cited: 493.1291 Test report. 493.1407 Laboratory director responsibilities. . D5807 TEST REPORT CFR(s): 493.1291(d) (d) Pertinent "reference intervals" or "normal" values, as determined by the laboratory performing the tests, must be available to the authorized person who ordered the tests and, if applicable, the individual responsible for using the test results. This STANDARD is not met as evidenced by: . Based on observation, document review, and interview with the laboratory personnel, the laboratory failed to ensure four of fifteen Urinalysis reference intervals were available to the authorized person responsible for using the test results. Findings are as follows: 1. The laboratory performed urinalysis testing as confirmed by the Technical Consultant (TC) during a tour of the laboratory at 11:06 a.m. on 10/23/24. 2. A Nikon Eclipse E2000 microscope was observed as present and available for use for urine microscopic examination during the tour. 3. Four urine microscopic examination reference intervals established in the Urine Procedure: Macroscopic and Microscopic found in the Procedures binder were not included on a patient test report from 2/28/25 reviewed during the survey. See below: Analyte Patient Report Procedure White blood cells --- 0-5/hpf Red blood cells --- 0-3/hpf Epithelial Cells --- Negative Bacteria --- 0-3/hpf 4. In an interview at 1:47 p.m., the TC confirmed the Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- above findings. The laboratory performed approximately 843 urinalysis exams annually as indicated on the Form CMS-2567 provided by the laboratory on the date of survey. . D6000 MODERATE COMPLEXITY LABORATORY DIRECTOR CFR(s): 493.1403 The laboratory must have a director who meets the qualification requirements of 493. 1405 of this subpart and provides overall management and direction in accordance with 493.1407 of this subpart. This CONDITION is not met as evidenced by: . Based on document review and interview with laboratory personnel, the Laboratory Director failed to provide overall management and direction to ensure successful participation in proficiency testing in 2023 and 2024. Findings are as follows: 1. The laboratory director failed to ensure the laboratory was enrolled in in an HHS approved proficiency testing (PT) program as required under 493.831 for Virology testing performed in 2023 and 2024. See D6015. . D6015 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4) (e)(4) Ensure that the laboratory is enrolled in an HHS approved proficiency testing program for the testing performed and that-- This STANDARD is not met as evidenced by: . Based on observation, document review, and interview with laboratory personnel, the laboratory director failed to ensure the laboratory was enrolled in an HHS approved proficiency testing program for moderate-complexity Virology testing in 2023 and 2024. Findings are as follows: 1. The laboratory performed moderate- complexity RSV (respiratory syncytial virus) testing on patients 7-19 years old under the Virology subspecialty as confirmed by the Technical Consultant (TC) during a tour of the laboratory at 11:06 a.m. on 10/23/25. 2. A Quidel Sofia was observed as present and available for use for RSV testing during the tour. 3. The laboratory performed proficiency testing (PT) using the American Proficiency Institute (API) provider. 4. PT documentation for RSV was not found during review of the laboratory's 2023 and 3034 API PT records. The laboratory was unable to provide PT documentation or alternative verification of accuracy documentation for RSV testing completed in 2023 and 2024 upon request. 5. The laboratory was enrolled in and successfully performed PT for RSV testing in 2025 as verified by the laboratory's 2025 API PT records reviewed during the survey. 6. In an interview at 2:00 p.m. on 10 /23/25, the TC confirmed the above findings. In an email received at 11:27 a.m. on 10 /27/25, the TC indicated the laboratory performed 13 moderate-complexity RSV tests in 2023 and 10 moderate-complexity RSV tests in 2024. . -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 28, 2023

Survey Type: Standard

Survey Event ID: GJY611

Deficiency Tags: D2128 D2128

Summary:

Summary Statement of Deficiencies D2128 HEMATOLOGY CFR(s): 493.851(e) (1) For any unsatisfactory analyte or test performance or testing event for reasons other than a failure to participate, the laboratory must undertake appropriate training and employ the technical assistance necessary to correct problems associated with a proficiency testing failure. (2) For any unacceptable analyte or testing event score, remedial action must be taken and documented, and the documentation must be maintained by the laboratory for two years from the date of participation in the proficiency testing event. This STANDARD is not met as evidenced by: . Based on document review and interview with laboratory personnel, the laboratory failed to take

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 17, 2019

Survey Type: Standard

Survey Event ID: QLPR11

Deficiency Tags: D6029 D6029

Summary:

Summary Statement of Deficiencies D6029 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(11) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(11) Ensure that prior to testing patients' specimens, all personnel have the appropriate education and experience, receive the appropriate training for the type and complexity of the services offered, and have demonstrated that they can perform all testing operations reliably to provide and report accurate results. This STANDARD is not met as evidenced by: . Based on document review and interview with laboratory personnel, the laboratory director failed to ensure initial training was documented for one of two newly hired testing personnel. Findings are as follows: 1. The laboratory performed Chemistry and Hematology testing as confirmed by Testing Personnel 4 during a tour of the laboratory on 10/17/19 at 1:25 p.m. 2. Testing personnel 7 (TP7) began working in the laboratory in April 2018 as indicated in laboratory records and confirmed by Technical Consultant 2 (TC2). TP7 met the qualifications to perform moderate complexity testing at 493.1423(b)(2) based on a review of education documents. 3. Chemistry and Hematology training documents for TP7 were not found during review of laboratory records. The laboratory was given an opportunity to provide the missing training records. 4. In an email communication received at 9:01 a.m. on 10/21/19, TC2 indicated documented Chemistry and Hematology training records for TP7 could not be found. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access